The amount and activity of active matrix metalloproteinase 13 is suppressed by estradiol and progesterone in human pelvic floor fibroblasts

Biology of Reproduction

Volumn 80, Issue 2, 2009, Pages 367-374

  Zong, Wenjun ^a,b   Meyn, Leslie A ^a   Moalli, Pamela A ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Estradiol; Fragmentation; Matrix metalloproteinase 13; Progesterone; Ubiquitin proteasome

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; COLLAGEN; COLLAGENASE 3; COLLAGENASE INHIBITOR; ENZYME PRECURSOR; ESTRADIOL; FULVESTRANT; PROGESTERONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME THERAPY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; OVARIECTOMY; PELVIC ORGAN PROLAPSE; PELVIS FLOOR; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; WESTERN BLOTTING;

ADNEXA UTERI; ADULT; ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; ESTRADIOL; FEMALE; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; OVARIECTOMY; PELVIC FLOOR; POSTMENOPAUSE; PROGESTERONE; RATS; RATS, LONG-EVANS; UTERINE PROLAPSE;

RATTUS;

EID: 59949087587     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.108.072462     Document Type: Article

References (29)

1. Carley ME, Turner RJ, Scott DE, Alexander JM. Obstetric history in women with surgically corrected adult urinary incontinence or pelvic organ prolapse. J Am Assoc Gynecol Laparosc 1999; 6:85-89.
2. Luber KM, Boero S, Choe JY. The demographics of pelvic floor disorders: current observation and future projections. Am J Obstet Gynecol 2001; 184:1496-1503.
3. DeLancey JO. Anatomic aspects of vaginal eversion after hysterectomy. Am J Obstet Gynecol 1992; 166:1717-1724.
4. Goh JTW. Biomechanical and biochemical assessment for pelvic organ prolapse. Curr Opin Obstet Gynecol 2003; 15:391-394.
5. Moalli PA, Talarico LC, Sung VW, Klingensmith WL, Shand SH, Meyn LA, Watkins SC. Impact of menopause on collagen subtypes in the arcus tendineous fasciae pelvis. Am J Obstet Gynecol 2004; 190:620-627.
6. Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ. Changes in metabolism of collagen in genitourinary prolapse. Lancet 1996; 347:1658-1661.
7. Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 1999; 189:300-308.
8. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000; 36: 1621-1630.
9. Murray GI. Matrix metalloproteinases: a multifunctional group of molecules. J Pathol 2001; 195:135-137.
10. Nagase H, Visse R. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92:827-839.
11. Kasper G, Glaeser JD, Geissler S, Ode A, Tuischer J, Matziolis G, Perka C, Duda GN. MMP activity is an essential link between mechanical stimulus and mesenchymal stem cell behaviour. Stem Cells 2007; 25: 1985-1994
12. Curry TE, Osteen KG. The matrix metalloproteinases system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endoc Rev 2003; 24:428-465.
13. Kremer EA, Chen Y, Suzuki K, Nagase H, Gorski JP. Hydroxyapatite induces autolytic degradation and inactivation of matrix metalloproteinase- 1 and -3. J Bone Miner Res 1998; 13:1890-1902.
14. Zong W, Zyczynski HM, Meyn LA, Gordy SC, Moalli PA. Regulation of MMP-1 by sex steroid hormones in fibroblasts derived from the female pelvic floor. Am J Obstet Gynecol 2007; 196:349.e1-349.e11.
15. Leeman MF, Curran S, Murray GI. The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol 2002; 37:149-166.
16. Knauper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, Zardi L, Murphy G. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997; 272: 7608-7616.
17. Wang HX, Wang HM, Lin HY, Yang Q, Zhang H, Tsang BK, Zhu C. Proteasome subunit lmp2 is required for matrix metalloproteinase-2 and -9 expression and activity in human invasive extravillous trophoblast cell line. J Cell Physiol 2006; 206:616-623.
18. Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JL, Klarskov P, Shull BL, Smith AB. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996; 175:10-17.
19. Moalli PA, Debes KM, Meyn LA, Howden NS, Abramowitch SD. Hormones restore biomechanical properties of the vagina and supportive tissues after surgical menopause in young rats. Am J Obstet Gynecol 2008; 199:161.e1-161.e8
20. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999; 19:1720-1730.
21. Tushaus L, Hopert AC, Strunck E, Schubert C, Wunsche W, Vollmer G. Estrogenic and antiestrogenic regulation of MMP-1 and MMP-13 mRNA in RUCA-I endometrial tumor cells in vitro and in vivo. Cancer Lett 2003; 198:99-106.
22. Lu T, Achari Y, Sciore P, Hart DA. Estrogen receptor alpha regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 transcriptional regulatory site. Biochim Biophys Acta 2006; 1762:719-731.
23. Pirila E, Ramamurthy N, Maisi P, McClain S, Kucine A, Wahlgren J, Golub LM, Salo T, Sorsa T. Wound healing in ovariectomized rats: effects of chemically modified tetracycline (CMT-8) and estrogen on matrix metalloproteinases -8, -13 and type I collagen expression. Curr Med Chem 2001; 8:281-294.
24. Schatz F, Kuczynski E, Kloosterbooer L, Krikun G, Buchwalder LF, Rahman M, Lockwood CJ. Tibolone exerts progestational inhibition of matrix metalloproteinase expression in human endometrial stromal cells. Steroids 2006; 71:768-775.
25. Zhang J, Hampton AL, Nie G, Salamonsen LA. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium. Biol Reprod 2000; 62:85-94.
26. Moalli PA, Klingensmith WL, Meyn LA, Zycznski HM. Regulation of matrix metalloproteinase expression by estrogen in fibroblasts that are derived from the pelvic floor. Am J Obstet Gynecol 2002; 187:72-79.
27. Lecker SH, Solomon V, Mitch WE, Golderg AL. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 1999; 129:227S-237S.
28. Fineschi S, Reith W, Guerne PA, Dayer JM, Chizzolini C. Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up- regulating metalloproteinase-1 production in human dermal fibroblasts. FASEB J 2006; 20:562-564.
29. Wang HM, Zhang X, Qian D, Lin HY, Li QL, Liu DL, Liu GY, Zhu C. Effect of ubiquitin-proteasome pathway on mouse blastocyst implantation and expression of matrix metalloproyeinases-2 and -9. Biol Reprod 2004; 70:481-487.